Wash. Tribal Corp. Says Stanford Used Its IP For Drug Patent
The Tulalip Tribal Federal Corp. has alleged that Stanford University secretly duplicated a potential opioid addiction treatment that was based on research involving the tribes' confidential information and funding, and that...To view the full article, register now.
Already a subscriber? Click here to view full article